CYTARABINE SANDOZ 20 mg/ml, solution for injection bottle, 5 ml
Active ingredients: Cytarabine
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injectionbottle, 5 mlintrathécale;intraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CYTARABINE SANDOZ 20 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intrathécale;intraveineuse;sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 5 ml
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Mar 2008
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67938406CIP73804992CIP133400938049923Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CYTARABINEsolution | 20 mg · 1 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.